Sandoz Pulls Methotrexate Lots Over Vial Defects

Law360, New York (October 29, 2010, 11:27 AM EDT) -- Sandoz Inc. has voluntarily recalled 24 lots of Sandoz- and Parenta-brand methotrexate injection after discovering glass flakes in vials of the medication that could be lethal in rare cases.

Sandoz, Novartis International AG’s generics maker, on Thursday issued the recall of all 50-milligram/ 2-milliliter and 250-mg/ 10-mL vials of methotrexate in the United States, reporting that the company’s quality control team had found flakes in a limited number of vials from four lots of the medication.

The flakes, the company said, were the product of a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.